Lev Pharmaceuticals Overview
- Status
-
Acquired/Merged
- Employees
-
26
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Lev Pharmaceuticals General Information
Description
Developer of therapeutic products for the treatment of inflammatory diseases. The company's product candidates are based on C1-esterase inhibitor (C1-INH), a human plasma protein that mediates inflammation and is potentially applicable as a treatment for a range of medical indications.
Contact Information
Corporate Office
- 675 Third Avenue
- Suite 2200
- New York, NY 10017
- United States
Corporate Office
- 675 Third Avenue
- Suite 2200
- New York, NY 10017
- United States
Lev Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lev Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lev Pharmaceuticals FAQs
-
Where is Lev Pharmaceuticals headquartered?
Lev Pharmaceuticals is headquartered in New York, NY.
-
What is the size of Lev Pharmaceuticals?
Lev Pharmaceuticals has 26 total employees.
-
What industry is Lev Pharmaceuticals in?
Lev Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Lev Pharmaceuticals a private or public company?
Lev Pharmaceuticals is a Private company.
-
What is the current valuation of Lev Pharmaceuticals?
The current valuation of Lev Pharmaceuticals is .
-
What is Lev Pharmaceuticals’s current revenue?
The current revenue for Lev Pharmaceuticals is .
-
When was Lev Pharmaceuticals acquired?
Lev Pharmaceuticals was acquired on 21-Nov-2008.
-
Who acquired Lev Pharmaceuticals?
Lev Pharmaceuticals was acquired by ViroPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
